No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
No Data
No Data
No Data
Amgen's Blincyto Data Send Cullinan Higher
Seeking AlphaApr 28 03:39
MorphoSys AG Announces Shift in Major Holdings
TipRanksApr 26 22:57
MorphoSys AG Sees Shift in Major Shareholders
TipRanksApr 26 00:00
MorphoSys AG Unveils Cancer Drug Trial Progress
TipRanksApr 24 23:57
MorphoSys AG Shares Shift in Major Holdings
TipRanksApr 24 22:57
MorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting
EQS-News: MorphoSys AG / Key word(s): ConferenceMorphoSys To Present New Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2024 ASCO Annual Meeting 24.04.2024 / 16:40 CET/
MorphoSysApr 24 12:00
No Data
No Data